Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03436277
Other study ID # LC-CUT-DMHC
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received February 11, 2018
Last updated February 18, 2018
Start date December 17, 2018
Est. completion date May 2019

Study information

Verified date February 2018
Source University of Guadalajara
Contact Diana M Hernández, PhD
Phone +521 3314856584
Email diana.hcorona@academicos.udg.mx
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.


Description:

A randomized, double-blind, placebo-controlled clinical trial will be carry out in 24 woman with body mass index ≥ 25 to 29.9 kg/m2. The patients will receive 1.5 g of L-Carnitine deluded in 250 ml of water or placebo before crossfit training, 5 times a week for 8 weeks. Before and after intervention the investigators evaluate: The body composition (body fat, lean body mass), arm muscle circumference, waist circumference, body weight and body mass index.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date May 2019
Est. primary completion date February 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Volunteers who practice crossfit regularly (who have 3 months prior to the beginning of the study practicing crossfit).

- Volunteers with a body mass index equal to or greater than 25 Kg/m2.

- Volunteers who do not have allergies to L-Carnitine or any of its components.

- Informed consent signed

- Women with a recommendation of nutrition two weeks prior to the start of the study.

- Body weight stable the last 3 months.

Exclusion Criteria:

- Volunteers with pathologies such as diabetes, hypertension, metabolic syndrome and allergies.

- Women with confirmed or suspected pregnancy.

- Women under lactation and/or puerperium.

- Hypersensibilility to L-Carnitine or Sucralose.

- Kown of renal, hepatic or thyroid deseased.

- Current or previous treatment diet (3 months before inclusion to the study).

- Current pharmacological treatment for loose body weight or 3 months before inclusion to the study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
L-Carnitine
L-Carnitine oral solution 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks
Dietary Supplement:
Sucralose
Sucralose 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

Locations

Country Name City State
Mexico Centro Universitario de Tonalá Tonalá Jalisco

Sponsors (1)

Lead Sponsor Collaborator
University of Guadalajara

Country where clinical trial is conducted

Mexico, 

References & Publications (6)

Behrend AM, Harding CO, Shoemaker JD, Matern D, Sahn DJ, Elliot DL, Gillingham MB. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. Mol Genet Metab. 2012 Jan;105(1):110-5. doi: 10.1016/j.ymgme.2011.09.030. Epub 2011 Oct 1. — View Citation

Broad EM, Maughan RJ, Galloway S DR. Effects of exercise intensity and altered substrate availability on cardiovascular and metabolic responses to exercise after oral carnitine supplementation in athletes. Int J Sport Nutr Exerc Metab. 2011 Oct;21(5):385-97. Epub 2011 Aug 3. — View Citation

Hongu N, Sachan DS. Carnitine and choline supplementation with exercise alter carnitine profiles, biochemical markers of fat metabolism and serum leptin concentration in healthy women. J Nutr. 2003 Jan;133(1):84-9. — View Citation

Huang A, Owen K. Role of supplementary L-carnitine in exercise and exercise recovery. Med Sport Sci. 2012;59:135-42. doi: 10.1159/000341934. Epub 2012 Oct 15. — View Citation

Kraemer WJ, Spiering BA, Volek JS, Ratamess NA, Sharman MJ, Rubin MR, French DN, Silvestre R, Hatfield DL, Van Heest JL, Vingren JL, Judelson DA, Deschenes MR, Maresh CM. Androgenic responses to resistance exercise: effects of feeding and L-carnitine. Med Sci Sports Exerc. 2006 Jul;38(7):1288-96. Erratum in: Med Sci Sports Exerc. 2006 Oct;38(10):1861. — View Citation

Villani RG, Gannon J, Self M, Rich PA. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab. 2000 Jun;10(2):199-207. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Body Fat Calulated by Durnin formula. Results are reported in percentage and kg 8 weeks
Primary Lean body mass Calulated by Durnin formula. Results are reported in percentage and kg 8 weeks
Primary Body Weight Subject go up onto the scale and stand still over the center of the scale with body weight evenly distributed between both feet. Omron hbf-514c an digital scale and results are reported in kg with a decimal. 8 weeks
Secondary Arm muscle circumference The right arm measure to the nearest centimeter with a measuring tape. Then, triceps skinfold thickness, an established measure of fat stores, measure to the nearest millimeter in the right arm using a skinfold caliper 8 weeks
Secondary Waist circumference Flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.
Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.
Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.
8 weeks
Secondary Body Mass Index Body mass divided by the square of the body height, and reported in units of kg/m2. 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04578067 - Empowering Immigrant Women for Active and Healthy Lifestyle N/A
Completed NCT02229708 - Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity N/A
Completed NCT00065052 - Modifying the Home Television Watching Environment N/A
Completed NCT04340388 - Contribution of Dolutegravir to Obesity and Cardiovascular Disease Phase 4
Completed NCT04997447 - Enforced Reduction in Physical Activity and Recovery in Older Adults N/A
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Completed NCT04559542 - Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes
Recruiting NCT04554758 - Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric Operation N/A
Recruiting NCT06078150 - Effects of Active Video Games on Chinese Overweight and Obese College Students' Physical and Mental Health N/A
Recruiting NCT02966444 - Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition N/A
Completed NCT01061346 - Effect of Dietary Fat When Eaten With Fructose Versus Glucose N/A
Recruiting NCT03917758 - Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors N/A
Active, not recruiting NCT06132269 - Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition N/A
Completed NCT03524521 - Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults N/A
Active, not recruiting NCT02737267 - Development of a Nutrigenetic Test for Personalized Prescription of Body Weight Loss Diets (Obekit) N/A
Completed NCT02554318 - Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia N/A
Completed NCT01820702 - Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation N/A
Completed NCT03480464 - App-technology to Improve the Level of Physical Activity After Bariatric Surgery N/A
Completed NCT03372109 - Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain N/A
Completed NCT03283657 - Diabetes Risk Education and Communication Trial N/A